Given P2X7’s crucial role in immune regulation and its involvement in tumor cell apoptosis, targeting this receptor presents a promising strategy for cancer therapy aimed at restoring immune activity within the tumor microenvironment. This evidence concerns the gene P2RX7 and neoplasm.